Morgan Stanley Maintains Underweight on Helmerich & Payne, Raises Price Target to $39

Benzinga Newsdesk www.benzinga.com Positive 80.2%

Neg 0% Neu 0% Pos 80.2%

Morgan Stanley analyst Daniel Kutz maintains Helmerich & Payne (NYSE:HP) with a Underweight and raises the price target from $35 to $39.